EUVIMEDEUVIMED entdecken
Crossref

ADAM8 Destroys the Endothelial Barrier and Promotes Leukocyte Extravasation to Aggravate Hepatic Ischemia–Reperfusion Injury

Ji Li, Wenwen Zhang, Yue Zhang, Huanqiu Liu iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202500697r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Ji Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Liver, ADAM Proteins, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Wujieping Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic ischemia–reperfusion injury (HIRI) is a local aseptic inflammatory response driven by innate immunity, and it can severely damage liver function. ADAM8 belongs to the ADAM (a disintegrin and metalloprotease domain) family and has been shown to be important in inflammation‐related diseases. However, its role in HIRI remains unknown. ADAM8 expression was increased in the liver tissues of HIRI mice, which was also correlated with the progression of liver damage. Suppression of ADAM8 alleviated I/R‐induced liver damage in mice, ameliorating hepatocyte injury and the release of inflammatory cytokines. ADAM8 knockdown upregulated the expression of CD31 and downregulated CD45 in liver tissues. In addition, ADAM8 knockdown downregulated Ly6G and citH3 double‐positive cells in the liver tissue of HIRI mice, reducing the protein expression of citH3, indicating ADAM8 knockdown relieved neutrophil infiltration and the formation of neutrophil extracellular traps during HIRI. In OGD/R‐treated C166 cells, ADAM8 was upregulated. ADAM8 knockdown inhibited endothelial cell permeability and neutrophil transmigration. Moreover, catalytic residue mutation of ADAM8 did not affect its protein expression but impaired the promotion of ADAM8 on endothelial cell permeability and neutrophil transmigration. BK‐1361, an inhibitor of ADAM8, also attenuated endothelial cell permeability and neutrophil transmigration. Animal experiments confirmed that BK‐1361 alleviates HIRI. These results suggested that the function of ADAM8 in disrupting the endothelial cell barrier and exacerbating leukocyte extravasation is dependent on its enzymatic activity. In summary, ADAM8 aggravates HIRI by disrupting the endothelial barrier, increasing endothelial permeability, accelerating leukocyte extravasation, and promoting the inflammatory response and hepatocyte injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryLiverADAM ProteinsMembrane ProteinsLeukocytesEndothelial CellsLiver DiseasesAnimalsMiceMaleMice, Inbred C57BLHumansNeutrophilsAntigens, CD

Stichwörter der Autor:innen

ADAM8endothelial barrierhepatic ischemia–reperfusion injuryleukocyte extravasation

Substanzen

ADAM ProteinsAdam8 protein, mouseMembrane ProteinsAntigens, CD

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Hospital of Jilin University, Changchun, Jilin, China.

ORCID-Profile: Huanqiu Liu

Förderung

  • Wujieping Medical Foundation

Zitieren

APA

Li, J., Zhang, W., Zhang, Y., & Liu, H. (2025). ADAM8 Destroys the Endothelial Barrier and Promotes Leukocyte Extravasation to Aggravate Hepatic Ischemia–Reperfusion Injury. The FASEB Journal. https://doi.org/10.1096/fj.202500697r

Vancouver

Li J, Zhang W, Zhang Y, Liu H. ADAM8 Destroys the Endothelial Barrier and Promotes Leukocyte Extravasation to Aggravate Hepatic Ischemia–Reperfusion Injury. The FASEB Journal. 2025. doi:10.1096/fj.202500697r

BibTeX
@article{Li2025,
  author = {Li, Ji and Zhang, Wenwen and Zhang, Yue and Liu, Huanqiu},
  title = {ADAM8 Destroys the Endothelial Barrier and Promotes Leukocyte Extravasation to Aggravate Hepatic Ischemia–Reperfusion Injury},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202500697r}
}
Kostenlos starten →